Document Detail


Resistin level is positively correlated with thrombotic complications in Southern Chinese metabolic syndrome patients.
MedLine Citation:
PMID:  20671416     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The metabolic syndrome (MetS) has been found to be closely related with thrombotic diseases. The mechanism, however, is far from elucidated.
AIM: This study was designed to investigate the relationship between endogenous resistin and thrombosis mediating factors, as well as its potential effects on the gene expression of cardiovascular disease biomarkers.
METHODS: Ninety patients satisfied the MetS criteria, and 55 healthy subjects were recruited as part of a single-center clinical study. Plasma levels of resistin, tissue factor (TF), tissue factor pathway inhibitor (TFPI), tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1) were measured by enzymelinked immunosorbent assays. The effect of resistin on the expression of cardiovascular disease biomarkers in human umbilical vein endothelial cells (HUVEC) was assayed by gene microarray.
RESULTS: 1) The average levels of resistin in MetS patients with or without acute myocardial or cerebral infarction were significantly higher than those of the controls. 2) The TF and TFPI increase was higher in MetS with infarction patients than in MetS patients. 3) In MetS with infarction patients, resistin was positively correlated with TF and PAI-1 (r=0.313, p=0.008; r=0.401, p=0.002, respectively). 4) In HUVEC, the microarray showed that apolipoprotein C-I, ACE, tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) and member 5 (CD40) genes expression were dramatically increased by resistin.
CONCLUSION: In patients with MetS, resistin is strongly associated with hypercoagulative and hypofibrinolitic activities. Moreover, resistin may induce thrombotic complications via mediating the lipoprotein metabolism and stimulating inflammation.
Authors:
W Q Fang; Q Zhang; Y B Peng; M Chen; X P Lin; J H Wu; C H Cai; Y F Mei; H Jin
Related Documents :
1581216 - Immunological studies in hiv seronegative haemophiliacs: relationships to blood product...
527616 - Infusion of purified antithrombin iii to patients with fracture of the neck of the femur.
10870806 - Human coagulation factor fviia (recombinant) in the management of limb-threatening blee...
12614366 - In vivo recovery and safety of human factor viii product aafact in patients with haemop...
23136236 - Successful treatment of cerebral venous sinus thrombosis with the solitiare fr thrombec...
12663336 - Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.
Publication Detail:
Type:  Journal Article     Date:  2010-07-29
Journal Detail:
Title:  Journal of endocrinological investigation     Volume:  34     ISSN:  1720-8386     ISO Abbreviation:  J. Endocrinol. Invest.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-04-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7806594     Medline TA:  J Endocrinol Invest     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  e36-42     Citation Subset:  IM    
Affiliation:
Department of ICU, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers ...
Next Document:  Effect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under con...